GHK-Cu Peptide: Published Research on the Copper Tripeptide

What is GHK-Cu?

GHK is the tripeptide glycyl-L-histidyl-L-lysine. According to a 2012 review, it was discovered in 1973 as an activity in human albumin that caused old human liver tissue to synthesize proteins like younger tissue; it has a high affinity for copper ions and readily forms the copper complex GHK-Cu ^[3]. An earlier review notes that GHK's affinity for Cu(2+) is similar to the copper transport site on albumin ^[2].

GHK is reported to be present in human plasma, saliva and urine, with levels that decline with age, and it is proposed to function as a complex with copper 2+ ^[4]. Research catalogues therefore distinguish the apo-peptide (GHK) from the copper complex (GHK-Cu), a distinction that a 2026 formulation review argues is often blurred in the literature ^[8].

What did the early collagen studies show?

The foundational in-vitro paper is Maquart and colleagues (1988), which reported that GHK-Cu stimulated collagen synthesis in fibroblast cultures. Stimulation began between 10^-12 and 10^-11 M, was maximal at 10^-9 M, and was independent of any change in cell number ^[1].

The same authors pointed out that a GHK triplet occurs in the alpha 2(I) chain of type I collagen, suggesting the tripeptide could be liberated by proteases at a wound site and act locally ^[1]. That hypothesis, GHK as a matrix-derived repair signal, frames much of the research that followed.

How is GHK-Cu linked to tissue remodeling?

A 2008 review grouped the reported activities of GHK and GHK-Cu into four clusters: chemoattraction of repair cells such as macrophages, mast cells and capillary cells; anti-inflammatory actions, including suppression of free radicals, thromboxane formation, transforming growth factor beta-1 and tumor necrosis factor alpha alongside increased superoxide dismutase; increased synthesis of collagen, elastin, metalloproteinases, anti-proteases, vascular endothelial growth factor, fibroblast growth factor 2 and nerve growth factor; and increased proliferation of fibroblasts and keratinocytes, nerve outgrowth and angiogenesis ^[2].

A 2015 review added that GHK stimulates both synthesis and breakdown of collagen and glycosaminoglycans and modulates the activity of both metalloproteinases and their inhibitors, a balance consistent with remodeling rather than simple matrix build-up. It also lists stimulation of dermatan sulfate, chondroitin sulfate and the small proteoglycan decorin, and reports that the molecule restores replicative vitality to fibroblasts after radiation therapy ^[4].

Animal-model findings are summarised in the same reviews. The 2015 review reports that the molecule accelerates wound healing of the skin, hair follicles, gastrointestinal tract, bony tissue and the foot pads of dogs, and that it induces systemic wound healing in rats, mice and pigs ^[4]. The 2008 review adds reports that GHK-Cu protects hepatic tissue from tetrachloromethane poisoning, blocks stomach ulcer development, and heals intestinal ulcers and bone tissue ^[2]. Because these are review summaries, readers designing studies should return to the primary papers for models and methods.

What do the gene-expression data suggest?

Later work from the same group moved from individual endpoints to genome-wide expression data. The 2015 review states that GHK is capable of up- and downregulating at least 4,000 human genes ^[4]. The 2018 review argues that recent genetic data may explain how one molecule shows such diverse actions, revealing multiple biochemical pathways regulated by GHK ^[5].

The 2018 review lists activities including stimulation of blood vessel and nerve outgrowth, support of dermal fibroblast function, restoration of COPD fibroblasts, suppression of NF-kappaB, DNA repair and activation of cell cleansing via the proteasome system. It reports tissue-repair findings for skin, lung connective tissue, bone, liver and stomach lining ^[5]. The 2012 review extended this to neurobiology, citing the ability of GHK to regulate genes critical for neuronal development and maintenance and proposing it as a candidate for study in age-associated cognitive decline ^[3]. These are hypothesis-generating reviews from a single research group, and the breadth of the claims should be read in that light.

What about antioxidant and anti-inflammatory research?

Antioxidant and anti-inflammatory effects recur across the literature. The 2012 review describes GHK as having antioxidant, anti-inflammatory and wound-healing properties, and frames oxidative stress and disrupted copper homeostasis as relevant research targets ^[3]. The 2008 review also lists blocking ultraviolet damage to skin keratinocytes and improving fibroblast recovery after X-ray treatments among the anti-inflammatory and protective actions attributed to GHK and GHK-Cu ^[2].

A 2025 materials study offers a recent example. Researchers loaded GHK-Cu onto hydroxyapatite microspheres by electrostatic adsorption and formulated them into a gel. The material showed sustained release over 7 days, and in an LPS-induced inflammation model in vivo and in vitro it reduced inflammatory factors and reactive oxygen species while increasing superoxide dismutase activity; histology showed significant collagen deposition ^[7].

Why is formulation such a large part of GHK-Cu research?

GHK is small and hydrophilic, which shapes how it behaves in formulations. A 2025 review on topical GHK notes formulation challenges arising from its high aqueous solubility, low partition coefficient and unstable nature. It reports that metal complexation and chemical modification with a hydrophobic moiety (as in palmitoylated Pal-GHK) increase permeability, and that cell-penetrating peptides and microneedle pretreatment are being studied as permeation-enhancement approaches ^[6].

The 2026 evidence-mapping review goes further, arguing that GHK-Cu is often treated as a single active ingredient despite formulation-dependent variation in coordination state, speciation, stability, pharmacokinetics and toxicity. Across delivery studies, it found that molar copper occupancy, labile copper, and release of intact GHK-Cu versus apo-GHK or free copper are usually not resolved ^[8]. For laboratories sourcing material, this points to analytical characterisation of identity, purity and copper content as a prerequisite for interpretable results.

How strong is the clinical evidence?

Older reviews describe controlled studies on aged skin reporting tighter skin, improved elasticity and firmness, and fewer fine lines ^[2]. More recent independent reviews are more cautious. The 2025 topical review found a surprising absence of clinical studies using GHK-Cu and Pal-GHK, despite their wide use in anti-wrinkle products ^[6].

The 2026 systematic evidence-mapping review concluded that preclinical data consistently support effects on matrix remodeling, epithelial repair, inflammatory and redox regulation, and angiogenesis, but that clinical evidence remains sparse. It notes that a 13-participant post-CO2-laser study was negative on objective endpoints, that a 2026 18-participant split-face study did not define GHK-Cu speciation or local exposure, and that the phase 2 acute-wound study NCT07437586 was still recruiting with no efficacy results. Its conclusion: GHK-Cu should be regarded as a promising but unproven therapeutic cargo rather than a clinically validated regenerative drug ^[8].

Frequently asked questions

What is GHK-Cu?

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK). GHK was discovered in 1973 as an activity in human albumin and has a high affinity for copper ions.

What was the first key finding on GHK-Cu and collagen?

A 1988 fibroblast-culture study reported that GHK-Cu stimulated collagen synthesis, beginning between 10^-12 and 10^-11 M and maximal at 10^-9 M, independent of changes in cell number.

Does GHK affect gene expression?

Review articles report that GHK can up- and downregulate at least 4,000 human genes. These analyses come largely from one research group and are best treated as hypothesis-generating.

Is GHK the same as GHK-Cu?

No. GHK is the apo-peptide and GHK-Cu is its copper complex. A 2026 review stresses that copper occupancy and speciation vary by formulation and are often not reported.

Is GHK-Cu clinically proven?

No. A 2026 systematic evidence-mapping review found clinical evidence sparse and described GHK-Cu as promising but unproven. It is supplied for laboratory research use only.

Cited studies

1. Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.. FEBS Lett. 238(2):343-6 (1988). PubMed 3169264 DOI
2. Pickart L. The human tri-peptide GHK and tissue remodeling.. J Biomater Sci Polym Ed. 19(8):969-88 (2008). PubMed 18644225 DOI
3. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.. Oxid Med Cell Longev. 2012:324832 (2012). PubMed 22666519 DOI
4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.. Biomed Res Int. 2015:648108 (2015). PubMed 26236730 DOI
5. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.. Int J Mol Sci. 19(7):1987 (2018). PubMed 29986520 DOI
6. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.. Bioimpacts. 15:30071 (2025). PubMed 39963574 DOI
7. Hu D, Zhang X, Gong S, et al. An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant.. Colloids Surf B Biointerfaces. 256(Pt 1):114982 (2025). PubMed 40716276 DOI
8. Mateescu DM, Gavrilescu DM, Mincioaga RI, et al. GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.. Pharmaceutics. 18(9):1077 (2026). PubMed 42797253 DOI